BATM Advanced Communications Ltd - Israel-based networking and medical technology company - says it has developed a new test for the rapid and comprehensive diagnosis of tuberculosis. Test takes two hours instead of several days with current methods. Clinical trials to start in second half of this year, fully funded by UN's Stop TB Partnership. Expects sales to begin next year.
Current stock price: 98.40 pence
Year-to-date change: up 5.8%
By Ivan Edwards; ivanedwards@alliancenews.com
Copyright 2021 Alliance News Limited. All Rights Reserved.


(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately repor...


(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:


(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:


(Alliance News) - BATM Advanced Communications Ltd on Monday reported a decline in profit during the first half of its current financial year despite ...


(Alliance News) - The following stocks are the leading fallers among London small-caps on Monday.


BATM Advanced Communications Ltd - Hod Hasharon, Israel-based provider of network infrastructure, cybersecurity and diagnostic technologies - Sells th...


(Alliance News) - BATM Advanced Communications Ltd on Monday said Ran Noy has resigned as chief financial officer to be replaced by Leor Miles with im...


BATM Advanced Communications Ltd - Hod Hasharon, Israel-based provider of real-time technologies for networking solutions and medical laboratory syste...


BATM Advanced Communications Ltd - Hod Hasharon, Israel-based provider of real-time technologies for networking solutions and medical laboratory syste...


(Alliance News) - BATM Advanced Communications Ltd on Monday announced an annual loss as expenses outpaced revenue growth.